| 000 | 01576 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250515151952.0 | ||
| 264 | 0 | _c20100618 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1461-7285 | ||
| 024 | 7 |
_a10.1177/0269881108099962 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKuloglu, M | |
| 245 | 0 | 0 |
_aSuccessful management of depression with reboxetine in a patient who developed Parkinsonism related to paroxetine use. _h[electronic resource] |
| 260 |
_bJournal of psychopharmacology (Oxford, England) _cApr 2010 |
||
| 300 |
_a623-4 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 |
_aAdrenergic Uptake Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aAntidepressive Agents, Second-Generation _xadverse effects |
| 650 | 0 | 4 |
_aDepressive Disorder, Major _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMorpholines _xtherapeutic use |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
| 650 | 0 | 4 |
_aParoxetine _xadverse effects |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 | _aReboxetine |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aCaykoylu, A | |
| 700 | 1 | _aEkinci, O | |
| 700 | 1 | _aBayindirli, D | |
| 700 | 1 | _aVural, G | |
| 700 | 1 | _aDeniz, O | |
| 773 | 0 |
_tJournal of psychopharmacology (Oxford, England) _gvol. 24 _gno. 4 _gp. 623-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0269881108099962 _zAvailable from publisher's website |
| 999 |
_c18527276 _d18527276 |
||